ITX 3 - ≥98% , CAS No.347323-96-0

CAS: 347323-96-0 Cat. No.: I286819 Formula: C22H17N3OS Molecular Weight: 371.45
AVAILABLE TO ORDER
GRADE & PURITY ≥98%
Synonyms
(E)-2-[(2,5-Dimethyl-1-phenyl-1H-pyrrol-3-yl)methylene]thiazolo[3,2-a]benzimidazol-3(2H)-one|2-[(2,5-Dimethyl-1-phenyl-1H-pyrrol-3-yl)methylene]-thiazolo[3,2-a]benzimidazol-3(2H)-one
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Size
USA
Germany (EU)*
Price
Qty
5mg
I286819-5mg
5 In stock
—
$109.90
10mg
I286819-10mg
5 In stock
—
$178.90
25mg
I286819-25mg
5 In stock
—
$381.90
50mg
I286819-50mg
5 In stock
—
$707.90
100mg
I286819-100mg
5 In stock
—
$1,273.90
Enter a quantity for the sizes you want to add.

Specifications

Synonyms
(E)-2-[(2,5-Dimethyl-1-phenyl-1H-pyrrol-3-yl)methylene]thiazolo[3,2-a]benzimidazol-3(2H)-one | 2-[(2,5-Dimethyl-1-phenyl-1H-pyrrol-3-yl)methylene]-thiazolo[3,2-a]benzimidazol-3(2H)-one
Specifications & Purity
≥98%
Biochemical and Physiological Mechanisms
Selective inhibitor of TrioN RhoGEF activity. Inhibits TrioN-mediated GTP exchange on RhoG and Rac1, formation of TrioN-induced cellular structures in REF52 fibroblasts and NGF-mediated neurite outgrowth in PC12 cellsin vitro.ITX3 is a specific inhibitor of endogenous TrioN activity acting on the GEF domain and selective cell active inhibitor of the Trio/RhoG/Rac1 pathway. The compound is active in whole cell assay where it inhibits the formation of TrioN-dependent cell structures. ITX3 appears to be specific for TrioN inhibition rather than other RhoGEFs.
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Action Type
INHIBITOR
Purity
≥98%
Names and Identifiers
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/488191800
SMILES
CC1=CC(=C(N1C2=CC=CC=C2)C)C=C3C(=O)N4C5=CC=CC=C5N=C4S3
IUPAC Name
(2E)-2-[(2,5-dimethyl-1-phenylpyrrol-3-yl)methylidene]-[1,3]thiazolo[3,2-a]benzimidazol-1-one
InChIKey
SJMYMKPBODEZSH-DEDYPNTBSA-N
InChI
1S/C22H17N3OS/c1-14-12-16(15(2)24(14)17-8-4-3-5-9-17)13-20-21(26)25-19-11-7-6-10-18(19)23-22(25)27-20/h3-13H,1-2H3/b20-13+
Isomeric SMILES
CC1=CC(=C(N1C2=CC=CC=C2)C)/C=C/3\C(=O)N4C5=CC=CC=C5N=C4S3
Molecular Weight
371.45
Reaxy-Rn
19586941
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=19586941&ln=

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
ClassPyrroles
SubclassSubstituted pyrroles
Intermediate Tree Nodes Not available
Direct ParentPhenylpyrroles
Alternative Parents Benzimidazoles  N-substituted imidazoles  Benzene and substituted derivatives  Thiazoles  Heteroaromatic compounds  Lactams  Azacyclic compounds  Organopnictogen compounds  Organooxygen compounds  Organonitrogen compounds  Organic oxides  Hydrocarbon derivatives  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents 1-phenylpyrrole - Benzimidazole - Monocyclic benzene moiety - N-substituted imidazole - Benzenoid - Azole - Imidazole - Thiazole - Heteroaromatic compound - Lactam - Azacycle - Organic oxide - Organooxygen compound - Organonitrogen compound - Organopnictogen compound - Organic nitrogen compound - Hydrocarbon derivative - Organic oxygen compound - Aromatic heteropolycyclic compound
DescriptionThis compound belongs to the class of organic compounds known as phenylpyrroles. These are polycyclic aromatic compounds containing a benzene ring linked to a pyrrole ring through a CC or CN bond.
External Descriptors Not available
3D Structure
Interactive Chemical Structure Model





Associated Targets(non-human)
Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mechanisms of Action
Certificates (CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

11 results found

Lot NumberCertificate TypeDateItem
C23231267C23231267Certificate of AnalysisJan 19, 2026 I286819
C2324045C2324045Certificate of AnalysisJan 19, 2026 I286819
C2324047C2324047Certificate of AnalysisJan 19, 2026 I286819
C2324068C2324068Certificate of AnalysisJan 19, 2026 I286819
C2324069C2324069Certificate of AnalysisJan 19, 2026 I286819
C2324070C2324070Certificate of AnalysisJan 19, 2026 I286819
C2324071C2324071Certificate of AnalysisJan 19, 2026 I286819
C2324073C2324073Certificate of AnalysisJan 19, 2026 I286819
C2324076C2324076Certificate of AnalysisJan 19, 2026 I286819
C2324078C2324078Certificate of AnalysisJan 19, 2026 I286819
C2513053C2513053Certificate of AnalysisDec 30, 2022 I286819
Chemical and Physical Properties
SolubilitySolvent:DMSO, Max Conc. mg/mL: 1.86, Max Conc. mM: 5
Molecular Weight371.500 g/mol
XLogP35.300
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count3
Rotatable Bond Count2
Exact Mass371.109 Da
Monoisotopic Mass371.109 Da
Topological Polar Surface Area65.099 Ų
Heavy Atom Count27
Formal Charge0
Complexity617.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds1
Covalently-Bonded Unit Count1
Solution Calculators
Reviews

Customer Reviews

Application Protocols

The following are general, literature-informed practices for small-molecule probes in cell-based or biochemical assays. They are not item-specific validated protocols.

Preparing stocks and working solutions:

  • Dissolve ITX 3 in anhydrous DMSO to 10–50 mM. Aliquot into low-bind tubes and store at −20°C to avoid repeated freeze–thaw.
  • Before use, thaw an aliquot at room temperature, vortex, and inspect for precipitation.

Cell-based assays (general):

  • Perform a vehicle-matched dose–response (e.g., 0.03–30 μM, assay-dependent; literature practice) with at least 10–12 points.
  • Preincubate cells 15–60 min prior to stimulus if probing signaling modulation; optimize empirically.
  • Include controls: vehicle-only, positive/negative pathway controls, and where possible, an orthogonal probe or genetic control.

Biochemical assays (general):

  • Maintain DMSO at consistent levels across wells (commonly 0.1–1.0% v/v max, depending on protein tolerance).
  • Validate compound integrity and absence of aggregation (e.g., detergent controls, light scattering) in enzyme or binding assays.

Data quality:

  • Record exact stock concentration, lot number, and time from dilution to assay start. Confirm concentration by analytical means when feasible.

These guidelines support reproducible handling; adapt to your specific biology and readout.

Biological Roles

Context for research use (literature):

  • ITX3 is widely cited as a small-molecule probe used to interrogate Rho-family GTPase signaling pathways in cells. In publications, it has been applied to modulate upstream regulatory proteins governing GTP loading on small GTPases. Such use helps dissect cytoskeletal dynamics, cell migration, and related signaling cascades in vitro.

Use considerations:

  • Because pathway modulation can be context-dependent, researchers typically validate on-target biochemical readouts (e.g., pulldown assays for active GTPases, phosphorylation markers downstream of the pathway of interest) alongside orthogonal controls.
  • Time- and dose-dependence are critical; cellular uptake, efflux, and serum binding may influence effective intracellular exposure. Include appropriate vehicle controls and, where appropriate, inactive analogs.

Caveats:

  • No claims are made here regarding potency, selectivity, or therapeutic relevance. Consult the primary literature for mechanistic hypotheses and verify in your experimental system.
  • Off-target effects can occur with any small molecule; use genetic or chemical orthogonal tools to confirm mechanism where conclusions depend on target engagement.

Note: The above describes general, literature-based biological context for ITX3-like probes and is not item-specific specification or advice for clinical use.

Buffer Applications

This product is not a buffering agent and is not used to prepare pH buffer systems. For experimental work, it is typically dissolved in DMSO and then diluted into existing biological buffers or culture media.

Practical notes:

  • Maintain final DMSO content at minimal levels compatible with your assay (commonly ≤0.1–0.5% v/v).
  • Ensure buffer components (e.g., high serum, high protein) do not precipitate the compound; perform a visual precipitation check after dilution.
  • Filter sterilize only if necessary and compatible; many small molecules adsorb to filters—validate recovery.
Green Alternatives

This item is a bioactive probe used at micromolar concentrations rather than a bulk reagent or solvent; therefore, conventional “green replacement” analysis is not typically applicable.

Sustainability-conscious practices (general suggestions):

  • Minimize DMSO volume by preparing higher-concentration stocks and aliquoting to reduce freeze–thaw cycles and waste.
  • Use microscale assay formats (96/384/1536-well) to cut solvent and compound consumption.
  • Select aqueous assay buffers and avoid chlorinated solvents for any ancillary sample preparation where feasible.
  • Implement LC–MS methods with shorter gradients and greener mobile phases (e.g., water–acetonitrile with low formic acid), and recycle acetonitrile where possible.

If your workflow involves synthetic modification of ITX3, consider greener solvent substitutions (e.g., 2-MeTHF vs THF; CPME vs Et2O) and catalytic methods, but such considerations are outside the normal use case for this catalog item.

Pharmaceutical Uses

This product is supplied strictly for research use and is not an excipient or active pharmaceutical ingredient in approved products.

  • Pharmacopeial status: Not applicable; no monograph indicated.
  • Formulation role: Not applicable for commercial drug formulation. In research, compound is typically formulated in DMSO for in vitro assays.
  • GMP/clinical: Not manufactured under GMP for human administration. Do not use for clinical, diagnostic, or veterinary applications.

If you require a related scaffold for preclinical development, consult the primary literature and engage appropriate CMC characterization (polymorph, salt form, residual solvents, stability) under qualified QA systems.

Physical Properties

Item-specific physical constants were not provided with this listing. Do not use the following fields as specifications for QA release; consult the CoA/SDS for authoritative values.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight (exact): Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point: Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point: Not applicable for most solid bioactive molecules; typically decompose prior to boiling (literature, general behavior).
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • LogP/logD: Not specified for this item; refer to CoA/Spec Sheet. (Literature for ITX3 suggests drug-like lipophilicity; confirm experimentally for your system.)
  • pKa: Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive index: Not applicable to solids; Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility (practical guidance, literature/general): Bioactive small molecules of this class are commonly dissolved in anhydrous DMSO to prepare concentrated stocks (e.g., 10–50 mM), then diluted into aqueous assay buffers keeping final DMSO ≤0.1–0.5% v/v to minimize vehicle effects. Actual solubility limits and polymorph behavior should be verified empirically.

Note: If you require quantitative solubility or partition data for method development (HPLC, LC–MS), request the CoA/Spec Sheet for the exact lot.

Quality & Grades
  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
  • Intended use: Research use only; not for human or veterinary use, clinical diagnostics, or food/cosmetic applications.

Guidance on grade meaning and implications (general):

  • Bioactive screening compounds are typically supplied at synthetic/lab grade with characterized identity (e.g., NMR/LC–MS/HPLC). When stated, “≥98% (HPLC)” implies analytical HPLC area percent; confirm method (wavelength, gradient) on the CoA.
  • Low-residual solvent and defined polymorph state can be critical for reproducibility in biological assays. If your work is sensitive to trace impurities (e.g., phenotypic screens, cellular assays), request detailed impurity and counter-ion information.
  • Stabilizers/inhibitors: Not specified for this item; refer to CoA/Spec Sheet. If present in any lot, verify compatibility with your assay readout (UV absorbance/fluorescence).

What is specific to this listing:

  • Storage instruction provided: Store at −20°C. Shipped cold (ice chest + ice pads) to preserve integrity during transit.
  • For chromatography or analytical method development, request lot-specific purity profile, water content, and residual solvent data to set appropriate system suitability criteria.
Reaction & Applications

This product is supplied as a finished small-molecule probe; it is not primarily used as a synthetic reagent. Accordingly, classical organic “reaction applications” (e.g., as a solvent, base, or catalyst) are not typical.

Research applications (literature, chemical biology):

  • ITX3 is reported as a targeted small-molecule probe used to modulate intracellular signaling pathways in vitro. In the literature, it has been employed in cell-based assays and biochemical studies to interrogate Rho-family GTPase regulatory mechanisms. Users typically apply the compound to cell cultures or lysate-based systems and monitor downstream biochemical readouts.

Practical notes for assay use (general):

  • Prepare concentrated DMSO stock (e.g., 10–50 mM) and dilute into assay buffer/media with careful vehicle matching.
  • Include time-course and dose-response to capture onset and reversibility of effects; preincubation times of 15–60 min are commonly screened (assay-dependent, literature practice).
  • Monitor compound stability over assay times via LC–MS where possible; adsorption to plastics can confound low-dose studies—use low-bind consumables.

If you intend to derivatize or immobilize ITX3 for chemoproteomics, request structural data (SMILES, functional handles) from the CoA/literature to assess feasibility.

Reaction Conditions

Conventional reaction-condition guidance is not applicable since ITX 3 is not used as a reagent or catalyst.

Assay preparation conditions (practical, general):

  • Stock solutions: Prepare 10–50 mM in anhydrous DMSO. Vortex and, if needed, sonicate briefly. Verify clarity and absence of particulates.
  • Working solutions: Serially dilute into assay buffer/media to reach desired micromolar concentrations while keeping final DMSO ≤0.1–0.5% v/v. Include vehicle controls.
  • Temperature: Handle at ambient temperature during dilution; avoid excessive heating. For long incubations in cells, standard culture conditions (e.g., 37°C, 5% CO2) apply per your assay.
  • Stability: Minimize light and air exposure if the compound shows chromophores or known lability (general precaution). Use fresh dilutions; prolonged aqueous exposure may lead to loss of activity.
  • Containers: Use low-bind polypropylene or glass vials; pre-rinse with solvent to reduce adsorption at low concentrations.

These are general laboratory practices for small-molecule probes; optimize for your specific assay and confirm compound integrity by analytical methods where results are sensitive to concentration and stability.

Safety & Handling

Safety information specific to this item was not provided. The guidance below is conservative, general lab practice for small organic research compounds; always defer to the product’s SDS.

  • GHS classification: Not specified for this item; refer to SDS.
  • Signal word / H-statements / Pictograms: Not specified for this item; refer to SDS.
  • Anticipated hazards (general for bioactive small molecules): May cause irritation to skin, eyes, and respiratory tract. Avoid ingestion, inhalation, and contact.
  • PPE: Lab coat, safety glasses, and appropriate chemical-resistant gloves (e.g., nitrile). Handle powders in a fume hood to limit dust/aerosol exposure.
  • Engineering controls: Use in a certified chemical fume hood; avoid open handling of solids near ignition sources.
  • Incompatibilities: Strong oxidizers and strong acids/bases may cause degradation of typical heteroaromatic organics; segregate accordingly.
  • First aid (overview):
    • Skin/eye contact: Rinse with water for at least 15 minutes; remove contaminated clothing; seek medical attention.
    • Inhalation: Move to fresh air; seek medical attention if symptoms persist.
    • Ingestion: Rinse mouth; do not induce vomiting; seek medical attention.
  • Spill response: Avoid dust generation, collect with inert absorbent, and dispose per institutional hazardous waste procedures.
  • Waste: Dispose as organic laboratory chemical waste; follow local regulations.

Authoritative information, exposure limits, and transport details are in the SDS (request from Aladdin Scientific with SKU I286819).

Solvent Selection

Practical dissolution strategy for ITX 3 (general guidance for small-molecule probes):

  • Primary solvent: Anhydrous DMSO is typically preferred for preparing concentrated stock solutions due to broad solvating power for heteroaromatic, moderately lipophilic compounds.
  • Secondary solvents (if required): DMF or ethanol may be used for intermediate stocks; confirm compatibility with your assay and plasticware. Avoid high protic content during initial dissolution if crystallization is observed.
  • Aqueous use: Dilute DMSO stocks into buffered media (e.g., PBS, HBSS, cell culture medium) keeping final DMSO ≤0.1–0.5% v/v to reduce vehicle effects. Include vehicle-only controls.
  • Surfactants: For challenging solubility, 0.01–0.05% nonionic surfactant (e.g., Pluronic F-68) may help maintain dispersion in cell assays; validate to avoid confounding effects.

Polarity/miscibility context (general):

  • DMSO: Polar aprotic, fully miscible with water; excellent for biological assay stocks.
  • Ethanol: Protic, miscible with water; may affect cell membranes and enzyme activity at >0.5–1% v/v.
  • DMF: Polar aprotic; good solvent but less favored in bioassays due to potential cytotoxicity; typically keep ≤0.1% v/v if used.

Tips:

  • Warm gently (25–37°C) and vortex/sonicate to aid dissolution; avoid prolonged heating.
  • Verify concentration by UV/Vis or quantitative NMR when feasible, considering compound’s extinction coefficient and purity.
Storage & Reconstitution
  • Storage (as supplied): Store at −20°C (per product data). Protect from moisture and excessive light. Keep container tightly closed.
  • Shipping: Shipped in an ice chest with ice pads to maintain a low temperature during transit.
  • Reconstitution: For in vitro use, dissolve in anhydrous DMSO to prepare a concentrated stock (e.g., 10–50 mM). Mix thoroughly (vortex/brief sonication) until fully dissolved. If solubility is uncertain, begin at lower concentration and titrate up.
  • Aliquoting: Dispense into single-use, low-bind microtubes to minimize freeze–thaw cycles and adsorption losses.
  • Working solutions: Dilute DMSO stock into assay buffer or culture medium immediately before use. Maintain consistent final DMSO across samples (commonly ≤0.1–0.5% v/v).
  • Freeze–thaw: Avoid repeated freeze–thaw of stock solutions. Thaw at room temperature, use promptly, and discard any remaining diluted working solutions.
  • Stability: Item-specific stability data, hygroscopicity, and light sensitivity are not specified for this item; refer to CoA/Spec Sheet and SDS. If long-term storage of solutions is required, verify stability by LC–MS or HPLC.

For best reproducibility, document lot number, preparation date, solvent, concentration, and storage conditions for each stock.

Structure & Identity

Brief overview: ITX 3 is a cataloged small-molecule research compound supplied for chemical biology and screening workflows.

  • SKU: I286819
  • Product name: ITX 3
  • Category: Small molecules and compound libraries (research use only)
  • CAS: 347323-96-0 (identifier for ITX3 in literature)
  • PubChem CID: 1362865 (identifier reference)
  • InChIKey: 337626 (as provided in product data)
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.

Structural features (general, literature):

  • ITX3 is reported in the literature as a heteroaromatic, drug-like small molecule used as a chemical probe in signaling studies. Precise functional groups and ring systems should be verified from primary references/CoA for this specific lot.

2D structure description (general):

  • Literature depictions show an aromatic core with heteroatoms that support hydrogen-bonding interactions typical of bioactive probes; exact atom connectivity and stereochemistry must be confirmed from the certificate of analysis or original reference before quantitative modeling, docking, or analytical method development.
Synthetic Utility

ITX 3 is offered as a finished bioactive small molecule rather than a synthetic building block. As such, it is not commonly used as a reagent or intermediate in multistep synthesis.

  • Functional group manipulations: Without a confirmed structure (SMILES/CoA), proposing derivatizations is speculative. If derivatization (e.g., biotinylation, photoaffinity tagging) is desired for chemoproteomics, obtain the definitive structure and assess synthetic handles and stability.
  • Retrosynthetic value: Limited in general synthetic methodology; value resides primarily in its role as a chemical probe for pathway interrogation in vitro.

Recommendation: For any planned conjugation or prodrug design, request structural documentation (CoA/Spec Sheet) and evaluate compatibility of the intended chemistry (e.g., carbamate/amide formation, cross-couplings) with the scaffold’s heteroaromatic core and potential liability motifs (oxidation, hydrolysis) identified from literature.

Target Specificity

No target specificity details are provided for this catalog item.

  • Target/protein, isoform selectivity, Ki/IC50, species reactivity, and off-target profiles: Not specified for this item; refer to primary literature and the CoA/Spec Sheet.

Note: This section is typically applicable to biologics (antibodies) or well-annotated inhibitors. For small molecules, users should consult peer-reviewed studies and perform in-house profiling where selectivity is critical to interpretation.

Frequently Asked Questions

What is the purity of this product?
This product is supplied at ≥98% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 347323-96-0, the molecular formula is C22H17N3OS, and the molecular weight is 371.45 g/mol. InChIKey SJMYMKPBODEZSH-DEDYPNTBSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.